Holen Sie sich die Stockscreener-App
0.00
100.00%
-8.16
Handel nachbörslich:
8.02
8.02
+
Schlusskurs vom Vortag:
$8.16
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$564.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.04M
KGV:
0.00
EPS:
-1.58
Netto-Cashflow:
$-27.38M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$8.345
Regulus Therapeutics Inc Stock (RGLS) Company Profile
Firmenname
Regulus Therapeutics Inc
Sektor
Branche
Telefon
858-202-6300
Adresse
4224 CAMPUS POINT COURT, SAN DIEGO, CA
Vergleichen Sie RGLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGLS
Regulus Therapeutics Inc
|
0.00 | 564.26M | 0 | -30.04M | -27.38M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Regulus Therapeutics Inc Stock (RGLS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-08-02 | Eingeleitet | Oppenheimer | Outperform |
| 2024-03-18 | Eingeleitet | Leerink Partners | Outperform |
| 2018-03-28 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2018-01-05 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-13 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-03-06 | Bestätigt | Wedbush | Outperform |
| 2017-01-30 | Herabstufung | Needham | Buy → Hold |
| 2017-01-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-12-07 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-11-02 | Bestätigt | Needham | Buy |
| 2016-07-25 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-06-28 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-06-28 | Bestätigt | FBR Capital | Outperform |
| 2016-06-28 | Bestätigt | Needham | Buy |
| 2016-06-07 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-04-13 | Eingeleitet | Chardan Capital Markets | Buy |
| 2015-12-04 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2015-04-21 | Fortgesetzt | FBR Capital | Outperform |
| 2014-11-24 | Eingeleitet | Deutsche Bank | Buy |
| 2014-08-07 | Bestätigt | FBR Capital | Outperform |
| 2013-08-14 | Bestätigt | Needham | Buy |
Alle ansehen
Regulus Therapeutics Inc Aktie (RGLS) Neueste Nachrichten
How strong is Regulus Therapeutics Inc. company’s balance sheetAI Powered Picks For Fast Growth - jammulinksnews.com
Is Regulus Therapeutics Inc. stock entering bullish territoryPattern Detection for Entry Confirmation Enabled - metal.it
Will Regulus Therapeutics Inc. stock split in the near futureChart Driven High Reward Trading Setup Presented - metal.it
Reversal Traders Monitor Regulus Therapeutics Inc. for EntryShort Term Buy Zone Stock Alerts Signal Entry - beatles.ru
What is the dividend policy of Regulus Therapeutics Inc. stockDynamic investment growth - jammulinksnews.com
What are the latest earnings results for Regulus Therapeutics Inc.Superior stock selection - jammulinksnews.com
What is Regulus Therapeutics Inc. company’s growth strategyAchieve breakthrough profits with smart strategies - jammulinksnews.com
How does Regulus Therapeutics Inc. compare to its industry peersOutstanding risk-reward balance - jammulinksnews.com
Does Regulus Therapeutics Inc. stock perform well during market downturnsConsistent wealth multiplication - jammulinksnews.com
How volatile is Regulus Therapeutics Inc. stock compared to the marketFree Consultation - jammulinksnews.com
When is Regulus Therapeutics Inc. stock expected to show significant growthUnlock daily market insights for better trades - jammulinksnews.com
What are analysts’ price targets for Regulus Therapeutics Inc. in the next 12 monthsGet professional advice for market timing - jammulinksnews.com
Is it the right time to buy Regulus Therapeutics Inc. stockUnlock powerful portfolio optimization tools - jammulinksnews.com
What analysts say about Regulus Therapeutics Inc. stockFree Market Volatility Navigation Tips - PrintWeekIndia
Is Regulus Therapeutics Inc. a good long term investmentTriple-digit growth rates - PrintWeekIndia
What drives Regulus Therapeutics Inc. stock priceHigh-yield trading alerts - Autocar Professional
Regulus Therapeutics Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com
Finanzdaten der Regulus Therapeutics Inc-Aktie (RGLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.43%
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):